Clinical Trials Browser

INDUSTRY × Neutropenia × Clear all

NCT04448301 2025-11-06

PC001- A Study to Evaluate the Usability of PointCheck

Phase NA Completed

Neoplasms, Neutropenia

NCT04618081 2025-07-08

Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)

Bone Marrow Failure Disorders, Lymphoma, Lymphoma, Non-Hodgkin, Neutropenia

NCT04174599 2025-04-20

Study to Compare the Efficacy and Safety of F-627 and GRAN®

Phase 3 Completed

242 enrolled 41 charts

Breast Neoplasms, Neutropenia

NCT04187898 2024-09-19

Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer

Phase 1 Completed

Breast Neoplasms, Neutropenia

NCT03433560 2024-05-14

An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)

Classical hematology

Neutropenia, Febrile Neutropenia

NCT02527746 2024-02-23

Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Phase 1 Completed

18 enrolled 22 charts

Breast Neoplasms, Neutropenia

NCT03252431 2023-07-03

Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Phase 3 Completed

393 enrolled 20 charts

Breast Neoplasms, Neutropenia

NCT05622058 2023-02-27

A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer

Phase 1 Terminated

Alopecia, Breast Neoplasms, Neutropenia

NCT02921802 2022-06-14

A Study of Special Use Results Surveillance of Revlimid 5mg Capsules

Classical hematologyMyeloidOtherPlasma cell

Arrhythmias, Cardiac, Constipation, Diarrhea, Heart Failure, Hemorrhage, Hypersensitivity, Infections, Multiple Myeloma, Myelodysplastic Syndromes, Myocardial Infarction, Neutropenia, Peripheral Nervous System Diseases, Thrombocytopenia, Tumor Lysis Syndrome, Lung Diseases, Interstitial, Renal Insufficiency, Venous Thromboembolism, Teratogenesis

NCT02922543 2022-06-14

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Classical hematologyOtherPlasma cell

Arrhythmias, Cardiac, Constipation, Diarrhea, Heart Failure, Hemorrhage, Hypersensitivity, Infections, Multiple Myeloma, Myocardial Infarction, Neutropenia, Peripheral Nervous System Diseases, Thrombocytopenia, Tumor Lysis Syndrome, Lung Diseases, Interstitial, Renal Insufficiency, Venous Thromboembolism, Teratogenesis

NCT01724866 2022-04-15

Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer

Phase 2 Completed

148 enrolled 45 charts

Neutropenia

NCT02643420 2022-03-02

ADVANCE

Phase 3 Completed

406 enrolled 19 charts

Breast Neoplasms, Neutropenia

NCT02953340 2022-03-02

SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide

Phase 3 Completed

237 enrolled 18 charts

Breast Neoplasms, Neutropenia

NCT02467868 2022-02-14

Efficacy and Safety Study With MYL-1401H and Neulasta

Phase 3 Completed

BreastClassical hematology

Breast Neoplasms, Neutropenia, Chemotherapy-Induced Febrile Neutropenia

NCT04466137 2022-02-09

Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy

Phase 3 Completed

Classical hematology

Neutropenia, Febrile Neutropenia

NCT02190721 2021-12-10

A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement

Phase 2 Completed

50 enrolled 39 charts

Neutropenia

NCT02872103 2021-05-05

Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Phase 3 Completed

122 enrolled 19 charts

Breast Neoplasms, Neutropenia

NCT03343145 2020-12-28

A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients

Phase 3 Completed

Breast Neoplasms, Neutropenia

NCT02135887 2020-12-22

MB-6

Gastrointestinal

Neutropenia, Colorectal Neoplasms

NCT02522234 2019-11-21

A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Phase 1/2 Completed

Neutropenia

NCT03251768 2019-09-13

Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients

Phase 2 Completed

Breast Neoplasms, Neutropenia

NCT02544685 2019-01-17

FENSY

Phase 2 Unknown

Classical hematology

Neoplasms, Neutropenia, Febrile Neutropenia

NCT03087370 2018-12-07

A Retrospective and Prospective Natural History Study of Patients With WHIM Syndrome

Classical hematology

WHIM syndrome, Primary Immunodeficiency Diseases, Agammaglobulinemia, Herpes Simplex, Infections, Neutropenia, Warts

NCT01648322 2018-10-03

Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Phase 2 Completed

232 enrolled 19 charts

Breast Neoplasms, Neutropenia

NCT02282215 2018-09-27

Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia

Phase 2 Completed

Other hematologic neoplasm

Fever, Infections, Leukemia, Neutropenia, Leukemia, Myeloid, Acute

NCT02005458 2018-07-17

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy

Phase 2 Completed

BreastClassical hematologyThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neutropenia, Febrile Neutropenia

NCT01619423 2018-07-06

PLIANT

Phase 1/2 Completed

186 enrolled 12 charts

Classical hematologyGastrointestinal

Neutropenia, Colorectal Neoplasms, Febrile Neutropenia

NCT02521441 2018-02-23

A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.

Phase 2 Completed

Neutropenia

NCT03404752 2018-01-19

Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.

Phase 3 Unknown

Breast Neoplasms, Neutropenia

NCT00911170 2017-12-29

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Phase 3 Completed

847 enrolled 21 charts

Classical hematologyGastrointestinal

Colonic Neoplasms, Fever, Neoplasms, Neutropenia, Rectal Neoplasms, Colorectal Neoplasms, Febrile Neutropenia

NCT00771810 2017-11-13

Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer

Phase 2 Completed

34 enrolled 19 charts

Classical hematologyGynecologic

Cytopenia, Anemia, Lymphopenia, Neutropenia, Ovarian Neoplasms, Thrombocytopenia

NCT01516736 2017-08-30

PROTECT2

Phase 3 Completed

308 enrolled 19 charts

Breast Neoplasms, Neutropenia

NCT02725606 2017-08-18

Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer

Phase 1 Unknown

Breast Neoplasms, Neutropenia

NCT03246009 2017-08-11

Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients

Phase 1 Completed

Breast Neoplasms, Neutropenia

NCT01735175 2017-08-07

PROTECT-1

Phase 3 Completed

316 enrolled 20 charts

Breast Neoplasms, Neutropenia

NCT00686543 2017-04-07

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Phase 4 Completed

75 enrolled 14 charts

Other hematologic neoplasm

Mycoses, Neutropenia, Leukemia, Myeloid, Acute

NCT00044486 2017-03-10

Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)

Phase 3 Completed

MyeloidOther hematologic neoplasm

Mycoses, Myelodysplastic Syndromes, Neutropenia, Leukemia, Myeloid, Acute

NCT00364468 2017-03-03

Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients

Phase 2 Completed

Lymphoma, Neutropenia

NCT01569087 2016-12-05

Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer

Phase 2 Completed

60 enrolled 17 charts

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT02104830 2016-10-24

Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

Phase 3 Completed

135 enrolled 18 charts

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT02778763 2016-07-20

Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis

Phase 2 Completed

Breast Neoplasms, Neutropenia

NCT02700360 2016-03-15

Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers

Phase 1 Completed

Neoplasms, Neutropenia

NCT02532712 2016-01-27

Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers

Phase 1 Completed

Neoplasms, Neutropenia

NCT01919710 2015-06-03

Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia

Phase 1 Completed

Neoplasms, Neutropenia

NCT01519700 2015-05-06

PIONEER

Phase 3 Completed

218 enrolled 15 charts

Breast Neoplasms, Neutropenia

NCT01060462 2014-05-15

Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients

Other hematologic neoplasm

Fever, Neutropenia, Hematologic Neoplasms

NCT02119715 2014-04-22

A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy

Phase 2 Completed

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT00115193 2013-08-29

Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma

Phase 2 Completed

Lymphoma, Non-Hodgkin, Neoplasms, Neutropenia

NCT01021683 2013-08-12

The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

203 enrolled 14 charts

Other hematologic neoplasm

Fever, Neutropenia, Hematologic Neoplasms

NCT00035594 2013-05-09

Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy

Phase 3 Completed

Breast Neoplasms, Neutropenia